Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 137 No. 2122 (2007)

Daily practice use of bortezomib in relapsed/refractory multiple myeloma: Safety/efficacy results of a compassionate use program in Switzerland

  • H Freimann
  • A Calderoni
  • P Cornu
  • R Olie
DOI
https://doi.org/10.4414/smw.2007.11716
Cite this as:
Swiss Med Wkly. 2007;137:317-322
Published
02.06.2007